{"blog": [], "keywords": [{"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "1", "is_major": "N"}, {"value": "Taxation", "name": "subject", "rank": "2", "is_major": "N"}, {"value": "Federal Taxes (US)", "name": "subject", "rank": "3", "is_major": "N"}, {"value": "Law and Legislation", "name": "subject", "rank": "4", "is_major": "N"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "5", "is_major": "N"}, {"value": "Mylan Inc", "name": "organizations", "rank": "6", "is_major": "N"}, {"value": "Teva Pharmaceutical Industries Ltd", "name": "organizations", "rank": "7", "is_major": "N"}, {"value": "Perrigo Company", "name": "organizations", "rank": "8", "is_major": "N"}], "web_url": "http://www.nytimes.com/2015/04/25/business/dealbook/the-unintended-twist-of-tax-inversions.html", "document_type": "article", "byline": {"person": [{"middlename": "Davidoff", "firstname": "Steven", "role": "reported", "rank": 1, "lastname": "SOLOMON", "organization": ""}], "original": "By STEVEN DAVIDOFF SOLOMON"}, "type_of_material": "News", "multimedia": [{"url": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof2-thumbWide.jpg", "legacy": {"wide": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof2-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof-drug-articleLarge-v3.jpg", "legacy": {"xlarge": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof-drug-articleLarge-v3.jpg", "xlargeheight": "601", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 601}, {"url": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof3-thumbStandard-v2.jpg", "legacy": {"thumbnail": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof3-thumbStandard-v2.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "959", "source": "The New York Times", "subsection_name": "DealBook", "lead_paragraph": "Mylan and Perrigo reincorporated overseas to lower their tax bills, but the move opened them up to unsolicited takeovers.", "pub_date": "2015-04-25T00:00:00Z", "news_desk": "Business", "headline": {"kicker": "Deal Professor", "main": "The Unintended Twist of Tax Inversions", "content_kicker": "Deal Professor"}, "print_page": "", "snippet": "Mylan and Perrigo reincorporated overseas to lower their tax bills, but the move opened them up to unsolicited takeovers.", "_id": "553ab88638f0d8230f3b0fbe", "slideshow_credits": null, "abstract": null}